Nucor

NUE · NYSE

$261.50+$0.77 (+0.30%)TodayMarket closed ·
Prev close $260.73

NUE analyst rating

BuyConsensus of 14 analysts over the last 12 months. 64% rate it a buy.
  • Strong buy0
  • Buy9
  • Hold5
  • Underperform0
  • Sell0

12-month price target · 20 analysts

Average $279.39 (+6.8% upside)

Low
$194.93
Now
$261.50
High
$325.50

Upgrades and downgrades

The latest rating actions, newest first

NUE analyst upgrades, downgrades and rating actions
FirmDateActionRating
BarclaysOct 19, 2026MaintainsOverweight
JP MorganOct 9, 2026MaintainsOverweight
KeybancOct 5, 2026MaintainsOverweight
Freedom BrokerSep 18, 2026DowngradeBuy → Hold
Wells FargoSep 18, 2026MaintainsOverweight
JP MorganSep 9, 2026MaintainsOverweight
Wells FargoAug 24, 2026MaintainsOverweight
Wells FargoJul 29, 2026MaintainsOverweight
BMO CapitalJul 29, 2026MaintainsOutperform
BarclaysJul 29, 2026MaintainsOverweight

The case for and against

Updated Dec 7, 2024

Bull case

Nucor Corporation is poised for a robust financial performance, particularly in the upstream raw materials segment, with expected sequential increases in profitability from its direct reduced iron (DRI) facilities in the second quarter of 2024. The consensus estimate for third-quarter 2024 EBITDA remains strong at $1.33 billion, highlighting the overall positive outlook for the company's earnings potential. While there may be some sequential declines anticipated due to seasonal factors and price softness in the sheet market, lower scrap costs are likely to provide a mitigating effect on profitability.

Bear case

Nucor Corp is facing a downturn in profitability, with expectations for 3Q'24 EPS significantly lower than consensus estimates and a pronounced decline in EBITDA compared to previous quarters. The company has indicated that both the steel mills and downstream steel products segments are expected to experience decreased profitability due to lower average selling prices and volumes. Furthermore, the outlook reveals concerns over persistent pricing pressures, leading to a revision of near-term earnings estimates downward and an anticipated EBITDA of approximately $0.8 billion for the upcoming quarter.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.